FDA Approves Use of Up to Three Tubes of Biofrontera Inc.’s Ameluz in One Treatment
The U.S. Food and Drug Administration (FDA) has approved the use of up to three tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) topical gel, 10% in one treatment with the BF-RhodoLED or RhodoLED XL lamps. This is up from the previous maximum of one tube. The Supplemental New Drug Application (sNDA) was supported by […]